CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) - Online First
Description text for Online First listing goes here...
33
results
1 - 20 of 33 results
-
-
Tau Pathology in Alzheimer's Disease: Bridging Molecular Mechanisms and Targeted Therapies
Authors: Mini Dahiya, Monu Yadav, Anil Kumar and Chetan GoyalAvailable online: 09 July 2025More LessAlzheimer’s disease (AD), the leading cause of dementia, is characterized by β-amyloid (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau. While Aβ-targeting therapies have been a primary focus of drug development, their long-term efficacy remains uncertain. Emerging evidence suggests that tauopathy is more closely linked to cognitive decline, positioning tau as a promising therape Read More
-
-
-
Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, Pharmacological, Nanoparticle, and Gene Therapy Approaches
Authors: Shalini Raghuvanshi, Avijit Mazumder and Saumya DasAvailable online: 09 July 2025More LessPersistent swelling in the brain, internal tau bundles, and external Amyloid-Beta (Aβ) deposits are characteristics of Alzheimer's Disease (AD), an ongoing neurodegenerative illness. Microglia are the main immune cells in the CNS (Central Nervous System). They keep the brain stable by keeping an eye on the immune system and removing apoptotic cells and protein clusters through a process called phagocytosis. Howev Read More
-
-
-
Neurotoxicity of Endogenous Neurotoxin Salsolinol in Parkinson's Disease
Authors: Shuang Wu, Yuan Zhou, Qiang Li, Huiyan Sun, Lida Du and Hongquan WangAvailable online: 09 July 2025More LessSalsolinol (SAL), an endogenous neurotoxin 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, is a dopamine metabolite that has been implicated in the pathogenesis of Parkinson’s disease (PD) due to its selective toxicity toward dopaminergic (DA) neurons. Experimental studies have demonstrated that SAL induces DA neuronal injury both in vitro and in vivo, thereby contributing to the PD pathogenesis. Given its Read More
-
-
-
TDP-43 Proteinopathies in ALS and FTLD: Mechanistic Insights and Therapeutic Approaches
Authors: Shilpi Chauhan, Preeti Maan and Archna PanghalAvailable online: 03 July 2025More LessTAR DNA-binding protein 43 (TDP-43) is a vital RNA/DNA-binding protein involved in RNA metabolism, playing a key role in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Approximately 97% of sporadic ALS (sALS), familial ALS (fALS) and FTLD cases are associated with pathological inclusions of hyperphosphorylated and ubiquitinated TDP-43 and genetic mutations in T Read More
-
-
-
β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets
Authors: Sudha Bansal, Monu Yadav, Priyanka Bisht, Divyanshi Bansal, Shiva Tushir and Dev RathoreAvailable online: 27 June 2025More LessAlzheimer's disease (AD) is a typical neurodegenerative illness, and it is a main cause of dementia, affecting millions of older populations throughout the world. Although the exact causes of AD are still not clear, the disorder is known to be considered by the accumulation of amyloid plaques and tau tangles in the neuronal cells. Currently, available drugs such as cholinesterase inhibitors and NMDA antagonists can hel Read More
-
-
-
Harnessing Nature's Bounty: The Neuroprotective Potential of Phytoconstituents and Nanotechnology in Neurodegenerative Disease Therapeutics
Authors: Siddhant Tripathi, Yashika Sharma and Dileep KumarAvailable online: 24 June 2025More LessInvestigations into the bioactive components of plant-based natural products indicate promising therapeutic potential for neurodegenerative diseases (NDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). The loss and dysfunction of neurons characterize these disorders. Effective therapeutic guidelines are still elusive despite advances in our comprehension of NDs, in part bec Read More
-
-
-
Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
Authors: Rohinee Dodiya, Pratishtha Sharma, Dipa Israni, Mohammad Amjad Kamal and Nigel H. GreigAvailable online: 11 June 2025More LessThe zebrafish (Danio rerio) is widely utilised as a live vertebrate model in research on neurological development and nervous system diseases. This species exhibits various distinctive attributes that render it well-suited for investigating neurological disorders such as Parkinson’s disease (PD). Zebrafish and humans have a genetic similarity of around 70%, and approximately 84% of the genes associated with human diseases h Read More
-
-
-
Mechanisms and Mitochondria-targeted Therapies for Retinal Ganglion Cell Degeneration in Glaucoma
Authors: Juanjuan Guan, Haibo Li and Kun XiongAvailable online: 10 June 2025More Less
-
-
-
Advances in Diagnostic Approaches for Alzheimer’s Disease: From Biomarkers to Deep Learning Technology
Available online: 27 May 2025More LessAlzheimer's disease (AD) is a devastating neurological disorder that affects humans and is a major contributor to dementia. It is characterized by cognitive dysfunction, impairing an individual's ability to perform daily tasks. In AD, nerve cells in areas of the brain related to cognitive function are damaged. Despite extensive research, there is currently no specific therapeutic or diagnostic approach for this fatal disease. However, s Read More
-
-
-
The NLRP3-P2X7 Axis and Cytokine Crosstalk in Alzheimer's Disease: Mechanisms, Implications, and Therapeutic Opportunities
Authors: Shubham Kurmi, Gaurav Doshi and Siddhi Bagwe ParabAvailable online: 21 May 2025More LessAlzheimer's disease (AD) is the primary cause of dementia in elderly individuals, characterized by progressive memory loss, cognitive decline, and impaired daily functioning. Pathologically, AD is associated with the accumulation of amyloid-β (Aβ) plaques, tau tangles, mitochondrial dysfunction, and chronic neuroinflammation. The activation of the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome by Aβ cluster Read More
-
-
-
Trends in Research on Gantenerumab for Alzheimer’s Disease: A Bibliometric and Thematic Analysis
Available online: 16 May 2025More LessIntroduction Gantenerumab (GR), a promising therapeutic agent for Alzheimer's disease (AD), has been the subject of extensive research. In this study, we aimed to provide a comprehensive analysis of the literature on GR. Methods A systematic search was conducted using the PubMed, Scopus, and Web of Science databases. VOSviewer and Bibliometrix were utilized to analyze bibliographic data. Results The analysis of t Read More
-
-
-
Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function
Available online: 12 May 2025More LessIntroduction Glioma, a global concern, a rare but aggressive brain cancer, poses a unique challenge for health scientists. The diagnosis solely depends on Magnetic resonance imaging (MRI) and computed tomography (CT) scans, which are effective but may lead to misinterpretation. Objective The present study explores outcomes and develops effective strategies for early detection of glioma. The study also focuses o Read More
-
-
-
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota
Available online: 12 May 2025More LessIntroduction Prenatal depression is a prevalent mental disorder that affects women during pregnancy. Alterations in the maternal microbiota have been linked to changes in the composition of the intestinal microbiota of foetus, which can have long-term consequences for the child's health. The gut-brain axis, which involves bidirectional communication between the gut and the brain, is believed to play a role in the development o Read More
-
-
-
Cell-Free DNA, a Noninvasive Biomarker for Prediction and Detection of Neurodegenerative Diseases, New Insights, and Perspectives
Available online: 28 April 2025More LessNeurodegenerative diseases pose serious threats to public health worldwide. Biomarkers for neurodegenerative disorders are essential to enhance the diagnostic process in clinical settings and to aid in the creation and assessment of effective disease-modifying treatments. In recent times, affordable and readily available blood-based biomarkers identifying the same neurodegenerative disease pathologies have been create Read More
-
-
-
Targeting PPARs in the Brain: From Old Knowledge to Emerging
Available online: 24 April 2025More Less
-
-
-
Pharmacological Perspective on the Neurobiology of PI3K-Akt-mTOR Signalling in Opioid Dependence
Authors: Aditi Singh, Heena Khan, Amarjot Kaur Grewal, Kamal Dua, Sachin Kumar Singh and Thakur Gurjeet SinghAvailable online: 17 April 2025More LessOpioid addiction is a condition of the central nervous system that occurs as a result of using opiate-based substances, which can be either natural or synthetic chemicals. These have effects identical to those of morphine and work by interacting with opioid receptors such as morphine, heroin, opium, buprenorphine, and Oxycontin. Dopamine has been suggested to play a role in the mechanisms linked to opioid addiction. Additi Read More
-
-
-
Neuroprotective Effect of Sitagliptin beyond the Incretin Effect: A Narrative Review
Authors: Ali Mohammad Pourbagher-Shahri and Fatemeh ForouzanfarAvailable online: 14 April 2025More LessSitagliptin is a dipeptidyl peptidase-IV inhibitor approved for treating type 2 diabetes mellitus. It increases the active form of incretin Glucagon-like Peptide-1 (GLP-1). The GLP-1 peptide prevents damage to neurons due to its anti-inflammatory and anti-apoptotic activities. This article summarizes the studies assessing the neuroprotective properties of sitagliptin, especially through the GLP-1 pathway. The outcomes of e Read More
-
-
-
Investigation and Mechanism of Coumarin for Potential Anti-Epileptic Targets using in-vitro SH-SY5Y Cell Line, Molecular Docking, and Network Pharmacology-based Analysis
Authors: Khan Dureshahwar and Momin Saloni TaufiqueAvailable online: 08 April 2025More LessBackground Epilepsy affects 1-2% of the world population. In about 30% of individuals with epilepsy, the etiology is unknown after ruling out genetic mutations, severe injury, and several other possible causes. In about 20-30% of epilepsy patients, anti-epileptic drugs fail to control the seizures. The general trend in epilepsy genetics research is towards an increasingly powerful genetic platform for investigating genomic sequenc Read More
-
-
-
Cannabidiol from Conventional to Advanced Nanomedicines for the Management of Cancer-Associated Pain
Authors: Abhishek Jain, Saba Qureshi, Km Rafiya, Irfan Ali, Mohd Shahrukh, Nazeer Hasan, and and Farhan Jalees AhmadAvailable online: 27 March 2025More LessChemotherapy-induced pain is one of the major challenges that hamper the patient's quality of life. Several cases of insufficient pain management were reported globally, especially in the case of patients who do not respond well to conventional pain management regimes and opioid analgesics. Additionally, conventional pain management has several shortcomings, and evidence suggests that cannabidiol has the potential to over Read More
-
-
-
Erythropoietin for Seizures and Epilepsy: Neuroprotective Effects, Mechanisms, and Contradictory Risks
Available online: 26 March 2025More LessBackgroundEpilepsy is a widespread neurological disorder, particularly affecting children and the elderly, presenting complex and varied challenges in management. Recently, erythropoietin has gained significant attention due to its neuroprotective effects, which have been demonstrated experimentally in various neurological conditions, including epilepsy. This review aims to analyze current literature on the role of erythro Read More
-
Most Read This Month Most Read RSS feed
Most Cited Most Cited RSS feed
-
-
A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
Authors: Dafin F. Muresanu, Alexandru V. Ciurea, Radu M. Gorgan, Eva Gheorghita, Stefan I. Florian, Horatiu Stan, Alin Blaga, Nicolai Ianovici, Stefan M. Iencean, Dana Turliuc, Horia B. Davidescu, Cornel Mihalache, Felix M. Brehar, Anca . S. Mihaescu, Dinu C. Mardare, Aurelian Anghelescu, Carmen Chiparus, Magdalena Lapadat, Viorel Pruna, Dumitru Mohan, Constantin Costea, Daniel Costea, Claudiu Palade, Narcisa Bucur, Jesus Figueroa and Anton Alvarez
-
-
-
- More Less